school children up to age two years in Nova Scotia, focussing on the number and timing of vaccine doses.
METHODS
The study cohort consisted of all children born January 1 to December 31, 2006 in Nova Scotia, as identified by the Nova Scotia Department of Health. Children born outside Nova Scotia were excluded. Of the 8,613 Nova Scotia live births identified, 368 (4.3%) did not have a well-baby visit or at least one vaccination recorded during their first 18 months of life. For privacy reasons, details of these babies were not provided to the study team and were excluded. It is likely these children were not immunized.
Vaccination information for each child up to two years of age was derived from the electronic MSI Physician Billings and paperbased public health records, which were entered into a computer database by a researcher. The number of doses of each vaccine received by month of age for each child, and the timeliness of administration, were calculated. Table 1 provides a summary of the four vaccines included: diphtheria, acellular pertussis, tetanus, polio, and haemophilus influenzae type b (DaPTP + Hib); pneumococcal conjugate (PNEU); meningococcal Group C (MENC); and measles, mumps and rubella (MMR). A dose was "up-to-date" if it was administered according to the schedule, defined as within 1 month at ages 2, 4, 6, 12 or 18 months (where age was dependent on specific vaccine). Vaccines administered outside these ages were considered "not up-to-date". Children were stratified into: up-todate, not up-to-date, and no immunizations.
Four indicators of community socio-economic status (median household income, unemployment rate, high school diploma rate, university degree rate) were derived from 2006 dissemination area (DA) census data. Each indicator was grouped into quintiles, and linked to individuals through their postal code of residence using the Postal Code Conversion File (PCCF+). 12 Urban/rural residential status was assigned to each individual using the population densitybased urban/rural indicator available from the PCCF+. The nine DHAs were grouped depending on whether the mode of vaccine provision was i) predominantly family physician (≥98% vaccines by family physician only), ii) predominantly public health (25% vaccines by public health only) or iii) a mix of physician and public health (>50% vaccines by a mix of physicians and public health). Logistic regression was used to evaluate vaccine completeness in relation to these indicators. The significance of each variable was assessed from the likelihood ratio test statistic. 13 Statistical analysis was completed in SAS 9.1. 14 A telephone questionnaire was administered to parents/ guardians of a sample of the cohort to determine vaccine completeness based on parental knowledge. First, a random sample of 1,500 babies was generated comprising an equal number from each of the nine DHAs to ensure geographic representativeness. Letters were sent to the parents/guardians of each child in the sample. Those who did not decline were telephoned by a researcher. Three attempts were made to make contact. Those agreeing to participate were asked to provide information from the child's vaccine record if available; otherwise the information was provided from memory. Vaccine completeness rates were stratified by whether or not the respondent was in possession of the written record. These data were used to validate the information derived from the administrative 
RESULTS
Overall vaccine completeness was 49%, 40% and 58% at 12, 18 and 24 months of age, respectively. Individually, DaPTP+Hib (82%) and pneumococcal conjugate (80%) had reasonable completeness at 12 months of age (Table 2) , when the schedule for these two vaccines required doses administered at 2, 4 and 6 months ( Figure 1 ). The rate for these two vaccines declined to around 50% complete at 18 months, when a fourth dose was due, before rising to just below 70% at 24 months. MMR (66%) and meningococcal Group C (58%) completeness was low at 12 months ( Table 2) . Uptake of these vaccines improved substantially in the following six months -24-month completeness rates were 86% for MMR and 81% for MENC ( Figure 1) . A small proportion of children (0.5-1%, depending on vaccine) received vaccinations early and these were classified as not up-to-date. There was no significant variation in vaccine completeness in relation to the child's sex, urban/rural residence, or income (results not presented). DHAs with a mix of public health-and physicianadministered vaccines had the highest completeness rates, followed by DHAs with vaccines predominantly administered through public health. The lowest rates were in DHAs with mostly physicianadministered vaccines (Table 3) . Vaccine completeness was significantly higher in the least-educated communities and in areas of higher unemployment.
Approximately 50% of the eligible telephone sample (1,500) could not be contacted. A total of 370 telephone questionnaires were completed (25% response); 130 (35%) of the respondents had a copy of the vaccine record. Survey respondents reported higher vaccine completeness compared to the corresponding administrative data (Table 4) .
DISCUSSION
Childhood immunization rates in Nova Scotia are suboptimal, putting many children at risk of potentially severe but preventable diseases. By the 24 months of age mark of the sample, none of the vaccines included in this study had coverage rates approaching the 90-95% rate recommended by the World Health Organization (WHO). 15, 16 Timeliness of vaccine administration was a major issue. The fourth dose of DaPTP+Hib and pneumococcal conjugate at 18 months was especially problematic and for many children provided late or not at all. Timely administration of the vaccines requir-NOVA SCOTIA VACCINE COVERAGE STUDY ing one dose at 12 months was also poor and many children were under-immunized for MMR and meningococcal group C for many months following their first birthday. Immunization rates were consistently higher in areas of higher unemployment and lower educational attainment. DHAs where vaccines were provided by a mix of public health nurses and family physicians had the best completeness rates; by contrast, vaccine completeness was lowest where vaccines were provided predominantly by family physicians. Survey respondents indicated higher vaccine completeness compared to the administrative data. While many respondents relied on memory, one third had access to the vaccine record and completeness rates were between 16-19 percentage points higher than that recorded in the administrative data. However, even these rates are well below the recommended rate. The majority of parents answered the survey from memory and indicated higher completeness rates than the administrative data. We cannot state with certainty that the telephone survey was any more accurate than the administrative health data, although we would suggest that respondents providing data from the vaccine record provide the "gold standard". It is a concern that even for this subset of children, vaccine completeness rates were low.
Canada has no integrated surveillance system for monitoring vaccine uptake or co-ordinated schedule and hence comparison between provinces is problematic. The Nova Scotia overall immunization rate at 24 months (58%) was similar to that of Manitoba (61%) 17 but lower than that of British Columbia (66.5%) 18 and Ontario (70%). 19 The 24-month MMR rate compared favourably with that of Alberta (91%) 20 and British Columbia (75.3%), 18 but the DaPTP+Hib rate was lower than that of Alberta (90%) 20 and British Columbia (74.6%). 18 The Canadian National Reports on Immunization show much higher vaccine completeness rates across all antigens, including 94% for MMR. Indeed, in 2006, around 90% of respondents stated that their children were up-todate with all immunizations. 7 However, the national survey is a random survey of just 499 parents of children aged 20-40 months using parental self-report and is not directly comparable to our data (although it does include an unspecified number from Nova Scotia). 7 Vaccine completeness is generally reported to be lower in children from lower-income families or those with less-educated parents. [21] [22] [23] However, our findings in relation to unemployment and education are consistent with a study showing higher immunization rates in poorer, less-educated families. 24 This suggests that parents from poorer communities can be motivated and educated to follow immunization guidelines diligently. Conversely, individuals more educated and affluent may interpret or follow immunization guidelines differently. In Nova Scotia, the involvement of the public health service in vaccinations, alongside family doctors, improved completeness rates. This suggests that the public health service has an important role in vaccine provision. In some communities, public health may provide immunizations to families who cannot access a family physician.
Privacy issues raised by the Provincial Health Department resulted in the exclusion of 368 children from the study for whom no well-baby visit or vaccinations were recorded. This resulted in a slight overestimate of vaccine completeness and an underestimate of children with no vaccines, although this small number of children will not materially affect the findings. It is a limitation that we were not able to include details of the subcohort of unvaccinated children, which is a small but potentially vulnerable population. 25 We utilized administrative health records to estimate vaccine uptake and these data underestimated vaccine completeness compared to the parent survey, although the self-reported rates were still low. It is a limitation that individual-level data on income, education or employment were not available. We used DA-level socioeconomic census data. DAs are the smallest unit of census geography -consisting of between 400-700 individuals 26 -but not all individuals in a DA defined as low income will necessarily be poor. Although there will be a degree of misclassification in the socio-economic information, this would likely reduce the magnitude of the socio-economic association with vaccination.
Childhood immunization uptake in Canada is suboptimal. Few studies report immunization completeness at the level recommended by the WHO. Nova Scotia has a multi-million-dollar system of vaccine purchase and delivery but, as with many Canadian jurisdictions, no system for monitoring or evaluating uptake. We cannot state with certainty immunization rates in Nova Scotia, but both timeliness and completeness of childhood immunizations are of serious concern in the province. It is important that the NIS establish a common Canada-wide immunization schedule, and that appropriate recording systems to support monitoring of immunization coverage be established provincially. Work is required to elucidate the barriers and enablers to immunization to ensure that public health activities target families and communities most likely to be under-immunized. 
